Alison Betts, PhD, Takeda

With over 32 years of industry experience, Alison currently serves as the Global Head of DMPK & Modeling at Takeda. In this role, she leads a multi-site team across Boston and Japan, overseeing a diverse multi-modality portfolio spanning Oncology, GI, and Neuroscience from discovery through lifecycle management.

Prior to joining Takeda in 2023, Alison was the Vice President of Scientific Collaborations and a Fellow of Modeling & Simulation at Applied BioMath, where she served as the Principal Investigator for an NIH SBIR grant to develop a platform QSP model for ADCs.
The foundation of her career was built during a distinguished 25-year tenure at Pfizer, working across the UK and US. During her final decade there, she led the modeling and simulation group for the Oncology Research Unit, contributing to the relaunch of Mylotarg, the approval of Inotuzumab, and the discovery of Elranatamab.

A recognized leader in Systems Pharmacology, Alison has published 40 manuscripts and delivered more than 50 invited presentations globally. she holds a Ph.D. in Systems Pharmacology from the University of Leiden and a B.Sc. in Biochemistry from the University of St Andrews.